Menopause Drug's brain impact on sex drive studied
NCT ID NCT04677491
Summary
This study investigated whether ospemifene, a non-hormonal oral medication for postmenopausal vaginal symptoms, improves sexual function by affecting the brain. Researchers used brain scans (fMRI) to compare activity patterns in women with sexual interest-arousal disorders who took either ospemifene or a placebo for three months. The goal was to see if the drug's benefits come from local vaginal effects or from changes in how the brain processes sexual stimuli.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VULVOVAGINAL SIGNS AND SYMPTOMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hospital Clínic de Barcelona
Barcelona, Barcelona, 08036, Spain
Conditions
Explore the condition pages connected to this study.